2 drug(s) with this reaction
4,859 total reports
Oral Herpes has been reported as an adverse reaction across 2 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 4,859 adverse event reports mention oral herpes in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with oral herpes, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have oral herpes listed in their FDA adverse event reports, sorted by report count:
In addition to oral herpes, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
2 drug(s) manufactured by Haleon Us Holdings Llc have oral herpes listed in their FDA adverse event reports: DOCOSANOL, GLYCERIN, LIDOCAINE.
There are a combined 4,859 reports of oral herpes across 2 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.